By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650


SEARCH JOBS


Industry
Biotechnology






Company News
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 2 Study Of ISIS-APO(a) Rx In Patients With High Lp(a) 7/17/2014 9:38:10 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $1 Million From GlaxoSmithKline (GSK) For Advancing ISIS-TTR Rx 7/16/2014 9:05:47 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $1 Million From GlaxoSmithKline (GSK) For Advancing Hepatitis B Virus Program 7/2/2014 8:25:29 AM
Isis Pharmaceuticals, Inc. (ISIS) Earns $1 Million From GlaxoSmithKline (GSK) For Advancing ISIS-TTR Rx 6/24/2014 6:54:03 AM
Isis Pharmaceuticals, Inc. (ISIS) Could Get $2 Billion Gain From Heart Attack Trials 6/20/2014 7:09:10 AM
Isis Pharmaceuticals, Inc. (ISIS) Bags Another $10 Million Milestone Payment, This Time From Biogen Idec, Inc. (Massachusetts) (BIIB) 6/17/2014 6:45:47 AM
Isis Pharmaceuticals, Inc. (ISIS) Reports Final Phase 2 Data On ISIS-GCGR RX Showing Significant Reduction In Hba1c In Patients With Type 2 Diabetes 6/16/2014 6:52:24 AM
Isis Pharmaceuticals, Inc. (ISIS) To Present At The 2014 Wells Fargo Healthcare Conference 6/12/2014 7:54:14 AM
Isis Pharmaceuticals, Inc. (ISIS) To Host Investor Event To Discuss ISIS-GCGR Rx Phase 2 Data Presented At The 2014 American Diabetes Association Scientific Sessions 6/11/2014 6:19:06 AM
Isis Pharmaceuticals, Inc. (ISIS) Pockets $15 Million From AstraZeneca PLC (AZN) On ISIS-ARRx Study Initiation 6/10/2014 6:32:48 AM
12345678910...
//-->